Sinopharm said that preliminary data from last-stage trials had shown the vaccine to be 79.3% effective.Sinopharm said that preliminary data from last-stage trials had shown the vaccine to be 79.3% effective.Read More

Sinopharm said that preliminary data from last-stage trials had shown the vaccine to be 79.3% effective.Sinopharm said that preliminary data from last-stage trials had shown the vaccine to be 79.3% effective.Read More